The journey after a cancer diagnosis often involves juggling schedules, managing treatment plans and trying to glean as much information from health care providers as possible — not to mention the emotions that one must process.
A renewed partnership agreement signed by Novartis and the World Health Organization (WHO) will drive the global push towards making leprosy history. The five-year extension of the partnership – which was first signed in 2000 – will see Novartis continue to donate multidrug therapy (MDT) medicines to treat leprosy up to the end of 2025.
In response to the disproportionate and devastating impact COVID-19 has had on Black communities and other underserved communities of color, the first of hundreds of COVID-19 testing, vaccine awareness and education events nationwide took place at the historic Abyssinian Baptist Church in Harlem, January 25th.
The Zoological Lighting Institute™ announced today new partnership initiatives with the Zoo Animal Welfare Education Center in Bellaterra (Barcelona, SP), to underscore the importance of light for animal welfare, and animal welfare for human well being. The partnership includes co-sponsoring of professional course-work, the creation of data-driven preventative healthcare stations in aquariums and zoos, and related ex-pat public outreach initiatives around the globe.
The International WELL Building Institute (IWBI) today announced the launch of its Global Research Agenda, an interdisciplinary global call to action to support innovative health and built environment research, to unite disciplines...
As the world continues to battle COVID-19 and communities strive to get back to business, it is more important than ever to raise confidence in the safety of buildings and shared spaces. Today, Lady Gaga, Jennifer Lopez, Michael B. Jordan, Robert...
At Novartis, we work to build trust with society and deliver long-term value to our stakeholders by embedding environmental, social and governance (ESG) topics into the core of our business strategy and operations.
Ukko, a biotech company with the mission to eliminate food allergies and sensitivities, today announced USD 40 million in new Series B funding. Ukko harnesses artificial intelligence (AI) and protein engineering to develop healthier food...
Through our Goals That Inspire we strive to make a positive difference in our communities by relying on our ability to understand their needs and then...
We invent breakthrough technologies that enable life-changing products and experiences.We’re building on our legacy of technology leadership with 5G...
